Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
10 worst performing large-cap stocks last week: RTO, ALLY, MRNA, HUM, TSN, BEKE, ADBE, RYAAY, JPM, DVN. Consider impact on your...
Cantor Fitzgerald analyst Sarah James reiterates Humana (NYSE:HUM) with a Neutral and maintains $395 price target.
RBC Capital analyst Ben Hendrix maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $385 to $400.
In collaboration with a leading researcher and professor at Harvard University, Humana's first-of-its-kind study found bett...
Members of Humana Inc.’s senior management team are scheduled to meet with investors and analysts at industry conferences and v...
https://news.sanfordhealth.org/news-release/sanford-to-end-contract-with-humana-medicare-advantage/
